| 07:00 - 08:15 | 195 | MS01 Interdisciplinary diagnosis and evaluation of interstitial lung disease | Morning Seminar |
| 07:00 - 08:15 | 196 | MS03 Interpretation of CPET with arterial blood gas analysis | Morning Seminar |
| 07:00 - 08:15 | 197 | MS02 How to make long-term noninvasive ventilation succeed in patients with COPD: between myth and evidence | Morning Seminar |
| 08:30 - 10:30 | 199 | Paediatric Year in Review | Session |
| 08:30 - 10:30 | 200 | COPD: from lung transplantation to regeneration | Symposium |
| 08:30 - 10:30 | 201 | A global threat: biomass burning and respiratory health | Symposium |
| 08:30 - 10:30 | 202 | Update on lung cancer biology for clinicians | Symposium |
| 08:30 - 10:30 | 203 | Acute respiratory distress syndrome (ARDS): the role of prevention | Symposium |
| 08:30 - 10:30 | 204 | The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines | Symposium |
| 08:30 - 10:30 | 205 | Phenotyping and monitoring asthma and COPD | Oral Presentation |
| 08:30 - 10:30 | 206 | Tuberculosis epidemiology: novel features | Oral Presentation |
| 08:30 - 10:30 | 207 | Diagnosis and treatment of pleural mesothelioma | Oral Presentation |
| 08:30 - 10:30 | 208 | Best abstracts in pulmonary rehabilitation and exercise training | Oral Presentation |
| 08:30 - 10:30 | 209 | TH17 and other acute asthmatic responses | Oral Presentation |
| 08:30 - 10:30 | 210 | The MRI modality becomes clinically mature: lung MRI | Oral Presentation |
| 08:30 - 10:30 | 211 | Pathogenetic mechanisms in pulmonary fibrosis | Oral Presentation |
| 08:30 - 10:30 | 212 | The story continues: impact of OSA on cardiometabolic parameters | Poster Discussion |
| 08:30 - 10:30 | 213 | Asthma or COPD: comorbid condition or a poorly understood single disease? | Poster Discussion |
| 08:30 - 10:30 | 214 | Bronchoscopic treatment of emphysema: where are we? | Oral Presentation |
| 08:30 - 10:30 | 215 | Animal models in respiratory drug development | Poster Discussion |
| 08:30 - 10:30 | 216 | New technologies and biomarkers in lung disease | Poster Discussion |
| 08:30 - 10:30 | 217 | Airways: reversibility and responsiveness | Poster Discussion |
| 08:30 - 10:30 | 218 | Mechanisms of COPD: proteases and a whole lot more | Poster Discussion |
| 10:45 - 12:45 | 221 | Ceremony for the ERS Pulmonary Arterial Hypertension Lifetime Achievement Award 2014 - Grand Round: "Pulmonary vascular involvement in systemic disease grand round - an interactive session" | Grand round |
| 10:45 - 12:45 | 222 | Asthma phenotyping: collaborative projects in Europe | Symposium |
| 10:45 - 12:45 | 223 | Rebuilding: new perspectives on lung bioengineering | Hot topics |
| 10:45 - 12:45 | 224 | End of the tobacco epidemic: from individual to societal strategies | Symposium |
| 10:45 - 12:45 | 225 | Noninvasive respiratory support for infants and young children | Symposium |
| 10:45 - 12:45 | 226 | Pneumonia and acute respiratory distress syndrome (ARDS): hot topics in clinical medicine and experimental research | Symposium |
| 10:45 - 12:45 | 227 | Bronchodilators for asthma and COPD | Oral Presentation |
| 10:45 - 12:45 | 228 | Mycobacterium tuberculosis infection: new therapeutic approaches | Oral Presentation |
| 10:45 - 12:45 | 229 | Clinical trials in IPF | Oral Presentation |
| 10:45 - 12:45 | 230 | Exercise training and physical activity in patients with COPD | Oral Presentation |
| 10:45 - 12:45 | 231 | Risk assessment and tracheal reconstructions | Oral Presentation |
| 10:45 - 12:45 | 232 | Advances in diagnosis and therapy of thoracic tumours | Oral Presentation |
| 10:45 - 12:45 | 233 | COPD exacerbations | Oral Presentation |
| 10:45 - 12:45 | 234 | Risk factors for respiratory disease | Poster Discussion |
| 10:45 - 12:45 | 235 | Cystic fibrosis: basic science, physiology and clinical aspects | Poster Discussion |
| 10:45 - 12:45 | 236 | Respiratory disease management in primary care | Oral Presentation |
| 10:45 - 12:45 | 237 | Respiratory function: quality and new technologies | Poster Discussion |
| 10:45 - 12:45 | 238 | The technical and diagnostic agenda in OSA | Poster Discussion |
| 10:45 - 12:45 | 239 | Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) | Poster Discussion |
| 10:45 - 12:45 | 240 | Systemic and airway biomarkers | Poster Discussion |
| 12:50 - 14:40 | 242 | ICU outcomes, sepsis and infections | Thematic Poster Session |
| 12:50 - 14:40 | 243 | Improving noninvasive ventilation efficacy | Thematic Poster Session |
| 12:50 - 14:40 | 244 | Clinical exercise physiology in health and COPD | Thematic Poster Session |
| 12:50 - 14:40 | 245 | Lung function testing: new findings and new approaches | Thematic Poster Session |
| 12:50 - 14:40 | 246 | Pathophysiological mechanisms at different scales | Thematic Poster Session |
| 12:50 - 14:40 | 247 | Alterations of exercise and lung function in different diseases | Thematic Poster Session |
| 12:50 - 14:40 | 248 | Multidimensional analysis of respiratory problems | Thematic Poster Session |
| 12:50 - 14:40 | 249 | Sleep disordered breathing 1 | Thematic Poster Session |
| 12:50 - 14:40 | 250 | Sleep disordered breathing 2 | Thematic Poster Session |
| 12:50 - 14:40 | 251 | Sleep disordered breathing 5 | Thematic Poster Session |
| 12:50 - 14:40 | 252 | Sleep disordered breathing 3 | Thematic Poster Session |
| 12:50 - 14:40 | 253 | Sleep disordered breathing 4 | Thematic Poster Session |
| 12:50 - 14:40 | 254 | Pulmonary hypertension: right ventricle and basic physiology | Thematic Poster Session |
| 12:50 - 14:40 | 255 | Chronic thromboembolic pulmonary hypertension | Thematic Poster Session |
| 12:50 - 14:40 | 256 | Pulmonary hypertension in lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 257 | Pulmonary hypertension: novel targets and drugs | Thematic Poster Session |
| 12:50 - 14:40 | 258 | Pulmonary hypertension: clinical management | Thematic Poster Session |
| 12:50 - 14:40 | 259 | Acute pulmonary embolism | Thematic Poster Session |
| 12:50 - 14:40 | 260 | New clinical evidence for asthma and COPD treatments | Thematic Poster Session |
| 12:50 - 14:40 | 261 | Infection, thoracic trauma and congenital lesions | Thematic Poster Session |
| 12:50 - 14:40 | 262 | Novel approaches in the management of lung transplant candidates and recipients | Thematic Poster Session |
| 12:50 - 14:40 | 263 | Epidemiology, scores and outcomes of respiratory infections | Thematic Poster Session |
| 12:50 - 14:40 | 264 | Cells, biofilms and biomarkers in respiratory infections | Thematic Poster Session |
| 12:50 - 14:40 | 265 | Healthcare, prevention and adjunctive treatments in respiratory infections | Thematic Poster Session |
| 12:50 - 14:40 | 266 | Resistance, bacteriological profile and comorbidities in respiratory infections | Thematic Poster Session |
| 12:50 - 14:40 | 267 | Different interesting issues in respiratory infections: 1 | Thematic Poster Session |
| 12:50 - 14:40 | 268 | Different interesting issues in respiratory infections: 2 | Thematic Poster Session |
| 12:50 - 14:40 | 269 | Tuberculosis: diagnosis | Thematic Poster Session |
| 12:50 - 14:40 | 270 | Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 | Thematic Poster Session |
| 12:50 - 14:40 | 271 | Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 | Thematic Poster Session |
| 12:50 - 14:40 | 272 | Tuberculosis: from epidemiology to therapy 1 | Thematic Poster Session |
| 12:50 - 14:40 | 273 | Tuberculosis: from epidemiology to therapy 2 | Thematic Poster Session |
| 12:50 - 14:40 | 274 | Tuberculosis: from epidemiology to therapy 3 | Thematic Poster Session |
| 12:50 - 14:40 | 275 | Biology and pathology of thoracic tumours | Thematic Poster Session |
| 12:50 - 14:40 | 276 | Therapy of thoracic tumours: clinical trials and case series | Thematic Poster Session |
| 12:50 - 14:40 | 277 | Epidemiology, pathogenesis and quality management of thoracic tumours | Thematic Poster Session |
| 12:50 - 14:40 | 278 | Diagnosis, imaging and surgery for thoracic tumours | Thematic Poster Session |
| 12:50 - 14:40 | 279 | Diagnosis of pleural effusions and mediastinal adenopathies | Thematic Poster Session |
| 12:50 - 14:40 | 280 | Medical education: web and internet | Thematic Poster Session |
| 12:50 - 14:40 | 281 | Latest insights in airway diseases | Thematic Poster Session |
| 13:00 - 14:30 | 282 | ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)" | Symposium |
| 13:00 - 14:30 | 283 | Understanding the benefit of current personalised medicine platforms | Symposium |
| 13:00 - 14:30 | 289 | Developing evidence-based guidelines for ERS: theory, practicalities and challenges | Symposium |
| 13:00 - 14:00 | 291 | ME05 Cutting edge analysis of physical activity data | Meet the expert |
| 13:00 - 14:00 | 292 | ME06 Starting clinical research in a limited resource environment | Meet the expert |
| 13:00 - 14:00 | 293 | ME07 Interpreting ventilator waveforms at the bedside | Meet the expert |
| 13:00 - 14:00 | 294 | AirPROM: can imaging and modelling take us beyond FEV1? | Session |
| 13:00 - 14:00 | 295 | Leading edge education and teaching | |
| 13:15 - 14:30 | 297 | NIV: therapeutic methods beyond standard ventilation | Practical Workshop |
| 13:15 - 14:30 | 298 | Optimisation of the weaning process & why secretion management and early mobilisation are important? | Practical Workshop |
| 13:15 - 14:30 | 299 | Monitoring patients during non-invasive ventilation | Practical Workshop |
| 13:15 - 14:30 | 301 | Hands-on practice with coils for treatment of advanced emphysema | Practical Workshop |
| 14:45 - 16:45 | 304 | Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I | Session |
| 14:45 - 16:45 | 305 | Sleeping Beauty and Prince Charming: gender differences in sleep disordered breathing (SDB) | Symposium |
| 14:45 - 16:45 | 306 | Interstitial lung disease (ILD) in children | Hot topics |
| 14:45 - 16:45 | 307 | Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases | Symposium |
| 14:45 - 16:45 | 308 | An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases | Symposium |
| 14:45 - 16:45 | 309 | Virulent topics in respiratory infections | Symposium |
| 14:45 - 16:45 | 310 | The future has started: emerging potentials for personalised asthma treatment | Oral Presentation |
| 14:45 - 16:45 | 311 | Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows | Hot topics |
| 14:45 - 16:45 | 312 | Outdoor and indoor environment: factors influencing respiratory diseases throughout the course of life | Oral Presentation |
| 14:45 - 16:45 | 313 | Genes and environment in asthma and COPD | Oral Presentation |
| 14:45 - 16:45 | 314 | Direct and indirect monitoring of comorbidities | Oral Presentation |
| 14:45 - 16:45 | 315 | Pathobiology of pulmonary hypertension | Oral Presentation |
| 14:45 - 16:45 | 316 | COPD physiopathology | Oral Presentation |
| 14:45 - 16:45 | 317 | Expanding the use of noninvasive ventilation in acute respiratory failure | Poster Discussion |
| 14:45 - 16:45 | 318 | Longitudinal studies of respiratory disease | Poster Discussion |
| 14:45 - 16:45 | 319 | Increasing the tool-kit: applying the latest technologies to advance respiratory disease research | Hot topics |
| 14:45 - 16:45 | 320 | Non inflammatory monitoring of airway diseases | Poster Discussion |
| 14:45 - 16:45 | 321 | Management of asthma and other respiratory diseases in primary care | Poster Discussion |
| 14:45 - 16:45 | 322 | Latest insights in pulmonary rehabilitation | Poster Discussion |
| 14:45 - 16:45 | 323 | Tuberculosis: from diagnosis to therapy and prevention | Poster Discussion |
| New level |
| 17:15 - 19:15 | 329 | Identifying the unmet needs in asthma: Who, why and how many? | Evening Symposium |